High-Priced Drugs Should Be Discussed Carefully Based on Characteristics of Diseases and Treatments: JMA Exec

Discussions on high-priced drugs should be done carefully based on the characteristics of the drugs in question and the diseases these drugs treat, an executive of the Japan Medical Association (JMA) said. Masaaki Miyakawa, an executive board member at the...read more